[15] An ongoing, multicenter study -- the First International Randomized Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment [18] (FIRM-ACT; www.firm-act.org) -- will ...
Lysodren (mitotane) is a drug primarily used to treat adrenal cortex carcinoma (ACC) and control Cushing’s syndrome in patients with adrenal tumors. It functions by inhibiting adrenal gland activity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback